Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India. It offers product formulations for anti-acne, dry skin, anti-aging, anti-fungal, anti-histaminic, anti-perspirant, antibiotics, skin lightening, hair care, steroid and keratolytic, sunscreen, vitiligo, miscellaneous, peri-orbital hyperpigmentation, anti-scar, topical antibiotics, antioxidants, and anti-scabies, as well as cosmeceutical and aesthetic categories. The company was founded in 2009 and is headquartered in Bengaluru, India.
| Current Price | ₹43.00 |
|---|---|
| Market Cap | ₹86 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products; Anti-infective Drugs; Antifungal Drugs |
| P/E Ratio | 7.5 |
| Beta (1Y) | 0.74 |
| Dividend Yield | 1.16% |
1. Dealing in Pharma Products-100%
Amwill Health Care Limited is trading at ₹43.00, with a market capitalisation of ₹86 Cr.
Amwill Health Care Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products; Anti-infective Drugs; Antifungal Drugs).
Amwill Health Care Limited has a P/E of 7.5.